Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALTHEQUITY, INC. Director's Dealing 2021

Feb 3, 2021

30722_dirs_2021-02-03_3f2e931f-d0ae-4fc0-8d31-81ab4876a6c9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEALTHEQUITY, INC. (HQY)
CIK: 0001428336
Period of Report: 2021-02-01

Reporting Person: DILLON ADRIAN T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-01 Common Stock A 2266 Acquired 30664 Direct
2021-02-01 Common Stock A 1044 Acquired 31708 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $46.40 2027-02-01 Common Stock (4837) 4837 Direct
Stock Option (right to buy) $50.41 2028-02-01 Common Stock (4339) 4339 Direct
Stock Option (right to buy) $63.64 2029-02-01 Common Stock (3626) 3626 Direct
Stock Option (right to buy) $32.50 2026-09-01 Common Stock (7632) 7632 Direct
Stock Option (right to buy) $66.06 2030-02-01 Common Stock (4012) 4012 Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 1,133 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2022. Vested shares will be delivered to the reporting person upon vesting.

F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 261 shares on February 1, 2021. The remaining restricted stock units vest as to 261 shares on each of May 1, August 1, and November 1, of 2021. Vested shares will be delivered to the reporting person upon vesting.

F3: The option is immediately exercisable.